1.EVALUATION OF URINARY PYRIDINOLINE AND DEOXYPYRIDINOLINE RATIO IN DISEASES WITH BONE LOSS
Zhiwei ZHAN ; Itsuo YAMAMOTO ; Rikushi MORITA
Medical Journal of Chinese People's Liberation Army 2001;0(07):-
To investigate the ratio of urinary pyridinoline (Pyr) and deoxypyridinoline (Dpyr) in diseases with bone loss, urinary Pyr and Dpyr levels were evaluated in 48 cases of osteoporosis, 8 cases of carcinoma with bone metastasis, 6 cases of rheumatoid arthritis, and 78 healthy volunteers. It was found that urinary Pyr and Dpyr increased significantly as compared to those in the control ( P 0 05), while it was dramatically lower in the patients with carcinoma bone metastasis ( P
2.Matrix Metalloproteinases and Their Inhibitors in Gastric Carcinoma.
Byung Sik KIM ; Yutaka YONEMURA ; Hideto FUJITA ; Naomi NOJIMA ; Taiichi KAWAMUTA ; Sachio FUSHIDA ; Takashi FUJIMURA ; Itsuo MIYAZAKI ; Kouichi MIWA ; Hiroshi ITOH ; Raul FALLA ; Yoshio ENDO ; Takuma SASKI ; Hiroshi YAMAMOTO
Journal of the Korean Cancer Association 1999;31(5):912-920
No abstract available.
Matrix Metalloproteinases*
;
Stomach Neoplasms
;
Tissue Inhibitor of Metalloproteinase-1
;
Tissue Inhibitor of Metalloproteinase-2